Retrospective, monocentric clinical study to evaluate the impact of induction therapy in patients with IIIA N2 lung cancer following surgical resectio
- Conditions
- C34Malignant neoplasm of bronchus and lung
- Registration Number
- DRKS00013150
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria
Stage IIIA N2 NSCLC
written informed consent
resectable tumor
Induction therapy
resection between 01.01.2009 and 31.12.2016
Exclusion Criteria
no written informed consent
irresectable tumor
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival
- Secondary Outcome Measures
Name Time Method diesease free survival